20 March 2024: Clinical Research
Serum Selenium Concentration as a Potential Diagnostic Marker for Early-Stage Colorectal Cancer: A Comparative Study
Michał Chalcarz 1ABCDE* , Beniamin Oskar Grabarek 2EF , Mateusz de Mezer 3E , Piotr Krokowicz 4BE , Janusz Patera 5F , Krzysztof Czupryna 2F , Jakub Żurawski 6AEFDOI: 10.12659/MSM.942882
Med Sci Monit 2024; 30:e942882
Table 1 The inclusion and exclusion criteria for both groups.
| Comparison group | Study group | |
|---|---|---|
| Inclusion criteria | 18 years old or over | 18 years old or over |
| Provision of informed, voluntary, written consent for participation in the study | Provision of informed, voluntary, written consent for participation in the study | |
| Exclusion of disease now and in the past | Colorectal cancer confirmed by histopathological examination | |
| Gallstones confirmed by ultrasound | ||
| Inguinal hernia confirmed with clinical and ultrasound examination | ||
| Exclusion criteria | Any previous surgeries or inflammation of the abdomen | Inoperable colorectal cancer |
| Below 18 years old | Below 18 years old | |
| Failure to provide informed, written consent for participation in the study | Failure to provide informed, written consent for participation in the study | |
| Cancer now or in the past | Occurrence of cancer other than colorectal cancer |